| 3 E Network Secures $1.2 Million Enterprise DDR4 Memory Sales Order |
Globe Newswire |
09/01 |
07:50 |
| ZenaTech to Showcase Drone as a Service Growth and ZenaDrone Defense Solutions at Series of U.S. and Global Investor and Defense Events |
Globe Newswire |
09/01 |
07:45 |
| NorthStrive Biosciences Expands AI-Driven Drug Discovery Program with Yuva Biosciences, Advancing Four Novel AI-Discovered Compounds Toward Lead Nomination for Potential Cardiac Disease and Obesity Therapeutic Applications |
Globe Newswire |
09/01 |
07:45 |
| Kala Bio and Virotek Announce Letter of Intent to Establish an Exclusive U.S. Distribution Partnership for Ophthalmology Genetic Testing Program |
Globe Newswire |
09/01 |
07:45 |
| USBC Expands Leadership Team with Former JPMorgan Chase and Coinbase Product Executive |
Globe Newswire |
09/01 |
07:30 |
| BridgeBio to Participate in September Investor Conferences |
Globe Newswire |
09/01 |
07:30 |
| Streamex Corp. Appoints Laura Kiernan as Head of Investor Relations |
Globe Newswire |
09/01 |
07:30 |
| FocalTherics™ to Present at the H.C. Wainwright 28th Annual Global Investment Conference |
Globe Newswire |
09/01 |
07:30 |
| Stoke Therapeutics and Biogen Announce Presentations of Clinical Data from Studies of Zorevunersen, an Investigational Medicine for the Treatment of Dravet Syndrome, at the 16th European Epilepsy Congress (EEC) |
Globe Newswire |
09/01 |
07:30 |
| Vera Therapeutics to Participate at Upcoming Investor Conferences |
Globe Newswire |
09/01 |
07:30 |
| Bitcoin Bancorp Reports Second Quarter Revenue and Raises Full-Year 2026 Revenue Outlook |
Globe Newswire |
09/01 |
07:30 |
| Telesat Government Solutions and Cailabs Collaborate on Secure Optical Connectivity for Government Missions |
Globe Newswire |
09/01 |
07:30 |
| KANZHUN LIMITED Announces Change of Directors’ Executive Positions |
Globe Newswire |
09/01 |
07:30 |
| Descartes Acquires Extensiv |
Globe Newswire |
09/01 |
07:15 |
| Invivyd Appoints Chairman Marc W. Elia as Chief Executive Officer; Approaches Results of VYD2311 studies DECLARATION and LIBERTY |
Globe Newswire |
09/01 |
07:01 |
| AAVantgarde appoints Megan Zoschg Canniere as Chief Regulatory & Quality Officer |
Globe Newswire |
09/01 |
07:00 |
| Auddia Announces Influence Healthcare’s First Specialty Hospital LOI, Marking a Major Milestone in the Company’s Healthcare Expansion |
Globe Newswire |
09/01 |
07:00 |
| NOVONIX Selected for South Korea-U.S. Infrastructure Initiative |
Globe Newswire |
09/01 |
07:00 |
| NetraMark Strengthens Board of Directors with Appointment of Veteran Pharmaceutical Executive Dr. Keith Fournier |
Globe Newswire |
09/01 |
07:00 |
| Yodeck Launches AI Agent for Digital Signage Management |
Globe Newswire |
09/01 |
07:00 |
| Aya Gold & Silver to Acquire Copper-Silver Portfolio |
Globe Newswire |
09/01 |
07:00 |
| BlossomHill Therapeutics to Present Updated Data from Ongoing Phase 1/2 SOLARA Trial of its Macrocyclic OMNI-EGFR™ Inhibitor, BH-30643, in EGFR-mutant NSCLC at the 2026 World Conference on Lung Cancer |
Globe Newswire |
09/01 |
07:00 |
| Lightbridge Receives Notice of Allowance on New Japanese Patent Covering Multi-Zone Fuel Element and 3D Printing Method |
Globe Newswire |
09/01 |
07:00 |
| Beam Therapeutics Appoints Eric Foster as Chief Commercial Officer |
Globe Newswire |
09/01 |
07:00 |
| Remix Therapeutics to Participate in Upcoming Investor Conferences |
Globe Newswire |
09/01 |
07:00 |
